- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00535444
Health and Faith Working to Control Blood Pressure
April 9, 2026 updated by: University of California, Los Angeles
Health and Faith Working Together to Control Blood Pressure
Faith community nursing programs have grown out of churches as a response to the inequity of healthcare delivery to uninsured and underinsured communities.
These programs provide outreach to community members and extend their services beyond just the parishioners of the churches, reaching more uninsured people than traditional medical services.
Although faith community nursing programs have been established throughout the United States, no evaluation of these programs has been done.
QueensCare is taking the lead in measuring the effect of parish nurses on health outcomes.
In this project we have one specific aim: to measure the effect of parish nurse visits on blood pressure control on community-dwelling hypertensive patients.
Our study will involve recruiting hypertensive patients from parish nurse led health fairs and interviewing subjects at the time of recruitment.
Patients will either be randomized to parish nurse visits or primary care physician appointments.
We will have a 4-month follow-up period with a re-check of blood pressures and an exit interview of the patient.
From this study, we hope to better understand if parish nurse visits improve blood pressure and medication compliance among hypertensive patients.
Study Overview
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- We will be including adults who are 18 years and older who have attended a health fair or screening event at one of QueensCare Health and Faith Partnership parish nurse sponsored church events in Los Angeles.
- Patients must be either English or Spanish speaking.
- Patients will be enrolled by blood pressure readings at the screening event. We will be using the JNC 71 criteria for diagnosing hypertension.
- Patients with blood pressures above 140/90 will be defined as hypertensive.
- Diagnosed and previously undiagnosed hypertensive patients will be included in the study.
- The patient must also be able to come to the follow-up appointment in 4 months.
Exclusion Criteria:
- Pregnant women will not be included in the study.
- Patients who do not speak English or Spanish will be excluded from the study since we do not have the capacity to translate all our materials into multiple languages.
- Those deemed by the research assistant to be incapable to give informed consent (due to intoxication, dementia, or other causes) will also be excluded from the study.
- Patients younger than 18 years old will be excluded from the study.
- Patients who have seen a parish nurse in her office hours in the past 6 months will be excluded from the study. We do not want patients who have an already established relationship with a parish nurse to be enrolled in the study with the chance of being randomized to the physician-only arm, which would interrupt the continuity of care the patient is receiving from the parish nurse.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control
assisted appointment with physician
|
One visit with the parish nurse in 2 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Drop of 12.5 mm Hg in systolic blood pressure
Time Frame: within 4 months
|
within 4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Arshiya A Baig, MD/MPH, UCLA RWJ CSP
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2006
Primary Completion (Actual)
October 1, 2007
Study Completion (Actual)
October 1, 2007
Study Registration Dates
First Submitted
September 25, 2007
First Submitted That Met QC Criteria
September 25, 2007
First Posted (Estimated)
September 26, 2007
Study Record Updates
Last Update Posted (Actual)
April 14, 2026
Last Update Submitted That Met QC Criteria
April 9, 2026
Last Verified
May 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- #G06-08-103-02A
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
Clinical Trials on Parish nurse visit
-
University of MichiganCompleted
-
Milton S. Hershey Medical CenterDepartment of Health and Human Services; Health Resources and Services Administration... and other collaboratorsCompletedPostpartum Depression | Dehydration | Jaundice | HyperbilirubinemiaUnited States
-
Ottawa Hospital Research InstituteUniversity of Ottawa; Bruyere Research Institute; College of Family Physicians...UnknownFamily Medicine | Well Child Care | Multidisciplinary Care
-
Children's Hospital Medical Center, CincinnatiPatient-Centered Outcomes Research InstituteCompleted
-
McMaster UniversityOntario Ministry of Health and Long Term CareCompleted
-
Johns Hopkins UniversityNational Institute of Nursing Research (NINR)Completed
-
Centre Hospitalier Universitaire de NīmesCompletedPreoperative AnxietyFrance
-
University of ChicagoWashington University School of Medicine; Agency for Healthcare Research and... and other collaboratorsEnrolling by invitationCOPD Exacerbation | Care TransitionsUnited States
-
National Bureau of Economic Research, Inc.National Institute on Aging (NIA)CompletedParticipation in Nurse VisitsUnited States
-
Michael Bau MortensenOdense University HospitalUnknownEsophageal Cancer | Gastro-esophageal Junction CancerDenmark